Stock 4SG SOL-GEL TECHNOLOGIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Sol-Gel Technologies Ltd. Deutsche Boerse AG

Equities

4SG

IL0011417206

Delayed Deutsche Boerse AG
Other stock markets
 11:30:47 26/06/2024 am IST 		5-day change 1st Jan Change
0.795 EUR +8.90% Intraday chart for Sol-Gel Technologies Ltd. +3.92% -26.39%
28/05 Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq MT
28/05 Sol-Gel Technologies Ltd. Announces Resignation of Gilad Mamlok as Chief Financial Officer, Effective September 21, 2024 CI

Chart calendar Sol-Gel Technologies Ltd.

2d26ecc212059002b3.sfHWDD8uxT4YXHBDwVVkryyGXf1_3ewjGMNzkisnznw.87C5SHB2ml81PgoTti8o-gHiMbUSsp9HWvMr83RWuT7gooJcWluKbC4KEw~3313b660e584fdb9224dd335ae61f463

Upcoming events on Sol-Gel Technologies Ltd.

08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
09/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Sol-Gel Technologies Ltd.

20/05/2024 04:30 pm Q1 2024 Earnings Release
13/03/2024 04:30 pm Q4 2023 Earnings Release
06/12/2023 10:30 pm Investor Meeting - Key Opinion Leader
09/11/2023 05:30 pm Q3 2023 Earnings Release
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
10/08/2023 04:30 pm Q2 2023 Earnings Release
26/07/2023 06:30 pm Annual General Meeting
12/05/2023 04:30 pm Q1 2023 Earnings Release
30/03/2023 06:00 pm H.C. Wainwright Autoimmune & Inflammatory Disease Conference
10/03/2023 05:30 pm Q4 2022 Earnings Release
27/01/2023 07:00 pm Acquisition of Patidegib by Sol-Gel Technologies Ltd Call
10/11/2022 02:30 pm Q3 2022 Earnings Release
04/08/2022 03:30 pm Interim 2022 Earnings Release
08/06/2022 06:00 pm Jefferies Healthcare Conference
24/05/2022 04:30 pm H.C. Wainwright Global Life Sciences Investment Conference
19/05/2022 06:30 pm Annual General Meeting
13/05/2022 04:30 pm Q1 2022 Earnings Release
30/03/2022 04:30 pm FY 2021 Earnings Release
25/03/2022 08:00 pm American Academy of Dermatology Meeting
10/01/2022 05:30 pm H.C. Wainwright BioConnect Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22,9
22,8
0.24%		8,77
8,30
5.74%		31,3
30,8
1.51%		3,88
5,68
-31.64%		1,55
1,17
32.71%
5,00

EBITDA
Million USD		Released
Forecast
Spread 		-25,1
-27,9
10.15%		-28,1
-37,2
24.54%		4,53
-2,69
268.18%		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-26,0
-26,6
2.3%		-30,2
-34,7
12.92%		2,96
0,74
303.08%		-16,2
-12,6
-28.63%		-29,3
-29,2
-0.25%
-24,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-24,6
-24,9
1.5%		-29,3
-33,8
13.28%		3,22
1,15
180.9%		-14,9
-11,7
-27.35%		-27,2
-28,2
3.52%
-23,2

Net income
Million USD		Released
Forecast
Spread 		-24,6
-24,9
1.37%		-29,3
-33,8
13.25%		3,22
1,15
180.9%		-14,9
-11,7
-27.35%		-27,2
-27,3
0.35%
-23,2

EPS
USD		Released
Forecast
Spread 		-1,26
-1,30
3.23%		-1,30
-1,48
12.31%		0,14
0,05
180%		-0,65
-0,50
-29.14%		-1,01
-1,01
0%
-0,83

Announcement Date24/03/2004/03/2130/03/2210/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		20,8
17,7
17.86%		0,00
1,40
-99.79%		3,52
4,61
-23.68%		0,26
3,45
-92.44%		0,10
1,84
-94.56%		0,76
0,48
59.58%		0,59
1,55
-61.76%		0,21
0,69
-69.24%		0,45
0,27
67.1%		0,47
0,56
-16.79%
1,61


1,18


1,75


1,30

EBIT
Million USD		Released
Forecast
Spread 		14,0
9,36
49.16%		-5,95
-6,83
12.93%		-0,46
-2,36
80.36%		-3,63
-1,65
-120.23%		-6,21
-3,01
-106.11%		-10,6
-5,93
-78.99%		-6,53
-7,20
9.3%		-6,31
-6,61
4.55%		-5,41
-5,33
-1.4%		-6,71
-4,84
-38.68%
-5,64


-6,22


-5,80




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		14,0
9,45
48.46%		-5,60
-6,82
17.91%		-0,13
-2,25
94.03%		-3,41
-1,50
-126.98%		-5,79
-2,89
-100.49%		-10,3
-5,59
-83.76%		-5,97
-6,88
13.25%		-5,71
-6,31
9.46%		-4,84
-5,08
4.85%		-6,34
-4,39
-44.51%
-5,31


-5,98


-5,58




Net income
Million USD		Released
Forecast
Spread 		14,0
9,45
48.46%		-5,60
-6,82
17.91%		-0,13
-2,25
94.03%		-3,41
-1,50
-126.98%		-5,79
-2,89
-100.49%		-10,3
-5,59
-83.76%		-5,97
-6,88
13.25%		-5,71
-6,31
9.46%		-4,84
-4,93
1.96%		-6,34
-4,39
-44.51%
-5,31


-5,98


-5,58




EPS
USD		Released
Forecast
Spread 		0,61
0,51
18.83%		-0,24
-0,29
17.24%		-0,01
-0,10
89.66%		-0,15
-0,07
-130.77%		-0,25
-0,13
-100%		-0,41
-0,22
-90.7%		-0,22
-0,26
13.73%		-0,21
-0,23
8.7%		-0,17
-0,18
2.86%		-0,23
-0,16
-43.75%
-0,19


-0,21


-0,20


-0,21

Announcement Date30/03/2213/05/2204/08/2210/11/2210/03/2312/05/2310/08/2309/11/2313/03/2420/05/24----

Upcoming sector events for Sol-Gel Technologies Ltd.

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Sol-Gel Technologies Ltd.

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SLGL Stock
  4. 4SG Stock
  5. Calendar Sol-Gel Technologies Ltd.